Developing combinatorial multi-component therapies (CMCT) of drugs that are more specific and have fewer side effects than traditional one drug therapies

Drugs designed for a specific target are always found to have multiple effects. Rather than hope that one bullet can be designed to hit only one target, nonlinear interactions across genomic and proteomic networks could be used to design Combinatorial Multi-Component Therapies (CMCT) that are more t...

Descripción completa

Detalles Bibliográficos
Autores principales: Liebovitch, Larry S, Tsinoremas, Nicholas, Pandya, Abhijit
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2007
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2008194/
https://www.ncbi.nlm.nih.gov/pubmed/17908289
http://dx.doi.org/10.1186/1753-4631-1-11

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2008194/
https://www.ncbi.nlm.nih.gov/pubmed/17908289
http://dx.doi.org/10.1186/1753-4631-1-11

Ejemplares similares